AC Immune

ACIU

----

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: AC Immune(ACIU) the Revenue is 18.7 M (+1036%), Miss estimate;the EBIT is 1.477 M (+106%), Miss estimate;the EPS is 0.0248 (+109.4%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.02B1036.33%

0.03B1971.60%

-0.02B935.27%

EBITMiss expectations

0.00B106.04%

0.02B165.45%

-0.01B59.41%

EPSMiss expectations

0.0248109.35%

0.1213145.83%

-0.096536.48%

Upcoming earnings report - Q3 FY2026

Available dateNov 4, 2026

Estimate Revenue$248.06 K

Estimate EBIT--

Estimate EPS-$0.1812

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly